Large Cap · Healthcare · Health Information Services
Large Cap · Healthcare · Health Information Services
Get the AI take on VEEV
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
72/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Lowest
$165
Median target
$235
Current price
$242.79
Highest
$350
Forward P/E
Favorable · 7% below avg
26.38x
Price / sales
Rich · Priced well above what its revenue alone supports
11.93x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
24.14x
EV / EBITDA
Rich · Operating earnings don't yet support this price
31.56x
ROIC
Strong · Comfortably clears the bar for efficient capital use
176.9%
ROE
Middle ground · Mixed
13.9%
Debt / equity
Favorable · 0.01 - strong leverage
0.01x
Current ratio
Strong · Comfortable room to cover bills due within a year
4.74x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $39.60B | 43.4 | +16.3% | 72 | |
| $11.53B | 22.0 | +19.7% | 78 | |
| $4.60B | 13.9 | +13.5% | 77 | |
| $33.87B | 35.4 | +15.5% | 77 | |
| $1.11T | 40.1 | +49.6% | 76 |